| 1 |
30154068 | [Cerebrospinal fluid examination after liposomal cytarabine intrathecal injection]. | 2018 Oct 1 |
1 |
| 2 |
22539243 | Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series. | 2012 Aug |
1 |
| 3 |
17311927 | The cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), can deliver Bcl-XL as an extracellular fusion protein to protect cells from apoptosis and retain differentiation induction. | 2007 Apr 13 |
1 |
| 4 |
17414574 | "Flushing out" cytosine arabinoside from CSF to reverse neurotoxicity. | 2007 Apr |
1 |
| 5 |
15925997 | Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. | 2005 Apr |
1 |
| 6 |
15934494 | GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDS. | 2005 Apr |
1 |
| 7 |
14984497 | Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. | 2004 Feb |
1 |
| 8 |
15736462 | Clinical response following adjuvant Temozolomide in a patient with primary cerebral lymphoma. | 2004 Nov-Dec |
1 |
| 9 |
12125986 | An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. | 2002 May |
2 |
| 10 |
10930995 | The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity. | 2000 Jul |
1 |
| 11 |
10363570 | Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes. | 1999 |
2 |
| 12 |
10374846 | Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor and Ara-C exert synergistic toxicity against human AML HL-60 cells. | 1999 Jun |
3 |
| 13 |
10450749 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial). | 1999 Aug |
2 |
| 14 |
10500838 | Effects of CSFS and their combinations with chemotherapeutic agents (CH) on leukemic blasts (LB) in children (MTT-assay). | 1999 |
1 |
| 15 |
10573139 | Modulation of in vitro chemosensitivity in acute myelogenous leukemia cell line by GM-CSF: opposing effects observed with different cytotoxic drugs and time exposure. | 1999 Oct |
6 |
| 16 |
9096697 | Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts. | 1997 Apr |
11 |
| 17 |
9639777 | Effect of concurrent use of rh-IL-3 and rh-GM-CSF on apoptosis of HL-60 cells induced by Ara-C. | 1997 |
1 |
| 18 |
8599980 | Effect of cytokines on the toxicity of cytostatic drugs on leukemic cells in vitro and in vivo. | 1996 Jan-Feb |
2 |
| 19 |
8642855 | Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy. | 1996 Mar |
1 |
| 20 |
8683977 | Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor. (GM-CSF). | 1996 May |
1 |
| 21 |
8819077 | Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers. | 1996 Jul |
2 |
| 22 |
8947585 | Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin. | 1996 Sep |
1 |
| 23 |
9031077 | Haemopoietic growth factors, the cell cycle of acute myeloblastic leukaemia progenitors and sensitivity to cytosine arabinoside. | 1996 Nov |
1 |
| 24 |
7577641 | Interleukin-3 priming in acute myeloid leukaemia patients. | 1995 Sep |
3 |
| 25 |
7885038 | GM-CSF and asparaginase potentiate ara-C cytotoxicity in HL-60 cells. | 1995 Mar |
3 |
| 26 |
7509013 | The effect of rh-cytokines on the sensitivity of normal human CFU-GM progenitors to Ara-C and on the S-phase activity of light density human bone marrow cells. | 1994 Feb |
1 |
| 27 |
7515298 | Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. | 1994 Mar |
5 |
| 28 |
7522289 | Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. | 1994 Sep |
2 |
| 29 |
7528449 | New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors. | 1994 Dec |
3 |
| 30 |
7801145 | Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia. | 1994 Dec |
2 |
| 31 |
8309245 | Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor. | 1994 Feb |
9 |
| 32 |
7685751 | Enhancement of cytosine arabinoside cytotoxicity by granulocyte/macrophage colony-stimulating factor and granulocyte colony-stimulating factor in a human myeloblastic leukemia cell line. | 1993 Apr |
5 |
| 33 |
7686602 | Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. | 1993 Jul |
4 |
| 34 |
7688839 | Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. | 1993 Aug |
1 |
| 35 |
7689660 | [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment]. | 1993 Jul |
2 |
| 36 |
7692194 | Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay. | 1993 Oct |
1 |
| 37 |
8326741 | Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow. | 1993 Jul |
2 |
| 38 |
8445942 | Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia. | 1993 Mar |
1 |
| 39 |
8462021 | Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines. | 1993 |
1 |
| 40 |
1450413 | Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. | 1992 Dec 1 |
1 |
| 41 |
1552225 | Myelosuppressive effects of cytosine arabinoside (Ara-C) on growth factor-dependent human long-term bone marrow cultures (LTBMC). | 1992 Jan |
3 |
| 42 |
1553573 | Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia. | 1992 Apr |
5 |
| 43 |
1560255 | Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors. | 1992 Feb |
2 |
| 44 |
1571541 | Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF. | 1992 May 1 |
2 |
| 45 |
1672790 | Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome. | 1991 Apr |
1 |
| 46 |
1719308 | Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. | 1991 Sep |
1 |
| 47 |
1760944 | Effects of recombinant human cytokines on cytarabine activity in K562 human myeloid leukaemia cells. | 1991 |
2 |
| 48 |
1801688 | In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML). | 1991 Dec |
1 |
| 49 |
1824260 | Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts. | 1991 Nov 15 |
4 |
| 50 |
1826536 | Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia. | 1991 Mar |
1 |